Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation

Journal of Interventional Cardiac Electrophysiology

Volumn 29, Issue 3, 2010, Pages 203-207

  Ahmed, Imdad ^a,b   Gertner, Elie ^a,b   Nelson, William B ^a,b   House, Chad M ^a   Zhu, Dennis W X ^a,b  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Anticoagulation; Defibrillator; Implantation; Pacemaker; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; ENOXAPARIN; HEPARIN; LEAD; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEFIBRILLATOR; DEVICE SAFETY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GENERATOR; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMATOMA; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT INFORMATION; POCKET HEMATOMA; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

EID: 78650677926     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-010-9520-6     Document Type: Article

References (22)

1. UK Wiegand D LeJeune F Boguschewski, et al. 2004 Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy Chest 126 1177 1186 10.1378/chest.126.4.1177 15486380 (Pubitemid 39391248)
2. GF Michaud F Pelosi Jr MD Noble BP Knight F Morady SA Strickberger 2000 A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation Journal of the American College of Cardiology 35 1915 1918 1:CAS:528:DC%2BD3cXktlGltb4%3D 10.1016/S0735-1097(00)00633-1 10841243 (Pubitemid 30342875)
3. C Marquie G De Geeter D Klug C Kouakam F Brigadeau O Jabourek N Trillot D Lacroix S Kacet 2006 Post-operative use of heparin increases morbidity of pacemaker insertion Europace 8 283 287 1:STN:280:DC%2BD283itVWntg%3D%3D 10.1093/europace/eul011 16627455 (Pubitemid 43905736)
4. MC Giudici SS Barold DL Paul P Bontu 2004 Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy PACE 27 358 360 15009863
5. DJ Milic ZD Perisic SS Zivic ZA Stanojkovic AM Stojkovic ND Karanovic NH Krstic SS Salinger 2005 Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment Europace 7 374 379 10.1016/j.eupc.2005.03.007 15944096 (Pubitemid 40790423)
6. A Chauhan AA Grace SA Newell, et al. 1994 Early complications after dual chamber versus single chamber pacemaker implantation Pacing and Clinical Electrophysiology 17 201202015 10.1111/j.1540-8159.1994.tb03791.x (Pubitemid 24362940)
7. RK Aggarwal DT Connelly SG Ray, et al. 1995 Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems British Heart Journal 73 571 575 1:STN:280:DyaK2Mzlt1emsQ%3D%3D 10.1136/hrt.73.6.571 7626359
8. AS Al-Khadra 2003 Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients PACE 26 511 514 12687880
9. DJ Goldstein W Losquadro HM Spotnitz 1998 Outpatient procedures in orally anticoagulated patients PACE 21 1730 1734 1:STN:280:DyaK1cvhsFKrtg%3D%3D 9744435
10. JM Tolosana P Berne L Mont M Heras A Berruezo J Monteagudo D Tamborero B Benito J Brugada 2009 Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial European Heart Journal 30 15 1880 1884 10.1093/eurheartj/ehp194 19487235 Epub 2009 May 31
11. Thal, S., Moukabary, T., Boyella, R., Shanmugasundaram, M., Pierce, M. K., Thai, H., et al. (2010). The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation. Pacing and Clinical Electrophysiology (in press).
12. V Pichette FA Leblond 2003 Drug metabolism in chronic renal failure Current Drug Metabolism 4 91 103 1:CAS:528:DC%2BD3sXjtVWmu74%3D 10.2174/1389200033489532 12678690 (Pubitemid 36443190)
13. NA Limdi TM Beasley MF Baird JA Goldstein G McGwin DK Arnett RT Acton M Allon 2009 Kidney function influences warfarin responsiveness and hemorrhagic complications Journal of the American Society of Nephrology 20 4 912 921 1:CAS:528:DC%2BD1MXltFyjsrg%3D 10.1681/ASN.2008070802 19225037 Epub 2009 Feb 18
14. P Boccardo G Remuzzi M Galbusera 2004 Platelet dysfunction in renal failure Seminars in Thrombosis and Hemostasis 30 5 579 589 1:CAS:528: DC%2BD2MXos1Oquw%3D%3D 10.1055/s-2004-835678 15497100 (Pubitemid 39426390)
15. LT Busby A Weyman GM Rodgers 2001 Excessive anticoagulation in patients with mild renal insufficiency receiving long term therapeutic enoxaparin American Journal of Hematology 67 54 56 1:STN:280:DC%2BD3M7ovFyrtg%3D%3D 10.1002/ajh.1077 11279659 (Pubitemid 32336706)
16. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification American Journal of Kidney Diseases 39 S1 10.1016/S0272-6386(02)70081-4
17. AL Weigert AI Schafer 1998 Uremic bleeding: pathogenesis and therapy The American Journal of the Medical Sciences 316 2 94 104 1:STN:280: DyaK1czmvVelsw%3D%3D 10.1097/00000441-199808000-00005 9704663 (Pubitemid 28371237)
18. M Keltai M Tonelli JF Mann E Sitkei BS Lewis S Hawken SR Mehta S Yusuf 2007 Renal function and outcomes in acute coronary syndrome: impact of clopidogrel European Journal of Cardiovascular Prevention and Rehabilitation 14 2 312 318 10.1097/01.hjr.0000220582.19516.a6 17446813 (Pubitemid 46650089)
19. N Thorevska Y Amoateng-Adjepong R Sabahi I Schiopescu A Salloum V Muralidharan CA Manthous 2004 Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin Chest 125 3 856 863 1:CAS:528:DC%2BD2cXivF2ltLs%3D 10.1378/chest.125.3.856 15006942 (Pubitemid 38367274)
20. C Tomkins A Cheng D Dalal, et al. 2010 Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation JACC 55 2376 2382
21. I Ahmed E Gertner WB Nelson CM House R Dahiya CP Anderson DG Benditt DW Zhu 2010 Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 6 745 749 10.1016/j.hrthm.2010.02.018 20176137
22. DJ Milic ZD Perisic SS Zivic, et al. 2005 Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment Europace 7 4 374 379 10.1016/j.eupc.2005.03.007 15944096 (Pubitemid 40790423)